Immucell (ICCC) Total Current Liabilities (2010 - 2026)
Immucell's (ICCC) quarterly Total Current Liabilities came in at $4.0 million in Q4 2025, down 9.84% YoY from $4.4 million in Q4 2024, and little changed on a QoQ basis from $4.0 million in Q3 2025.
Immucell (ICCC) Total Current Liabilities (2010 - 2026) Analysis & Trends
Immucell (ICCC) has 16 years of Total Current Liabilities data on file, last reported at $4.0 million in Q4 2025.
- Quarterly Total Current Liabilities fell 9.84% year-over-year to $4.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.0 million (down 9.84% YoY) and the FY2025 annual result came in at $4.0 million, down 9.84% from the prior year.
- Total Current Liabilities steadied at $4.0 million in Q4 2025, from $4.0 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $4.6 million in Q2 2024 to a low of $2.0 million in Q2 2021.
- A 5-year average of $3.5 million and a median of $3.9 million in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2021 — Total Current Liabilities decreased 14.47% — and 2023, when it soared 53.52%.
- Tracing ICCC's Total Current Liabilities over 5 years: stood at $2.5 million in 2021, then gained by 21.21% to $3.1 million in 2022, then surged by 36.63% to $4.2 million in 2023, then climbed by 5.12% to $4.4 million in 2024, then slipped by 9.84% to $4.0 million in 2025.
- The last three Total Current Liabilities figures came in at $4.0 million (Q4 2025), $4.0 million (Q3 2025), and $4.4 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.51 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 438.74 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 630.93 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 2.49 Bn |
| 10 | Immucell | 92.01 Mn | 83.15 Mn | 2.44 Mn | 4.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.44 Mn |
| Dec 31, 2025 | 3.98 Mn |
| Sep 30, 2025 | 4.00 Mn |
| Jun 30, 2025 | 4.45 Mn |
| Mar 31, 2025 | 3.87 Mn |
| Dec 31, 2024 | 4.41 Mn |
| Sep 30, 2024 | 4.47 Mn |
| Jun 30, 2024 | 4.56 Mn |
| Mar 31, 2024 | 4.18 Mn |
| Dec 31, 2023 | 4.20 Mn |
| Sep 30, 2023 | 3.33 Mn |
| Jun 30, 2023 | 4.19 Mn |
| Mar 31, 2023 | 3.84 Mn |
| Dec 31, 2022 | 3.07 Mn |
| Sep 30, 2022 | 2.71 Mn |
| Jun 30, 2022 | 2.73 Mn |
| Mar 31, 2022 | 2.57 Mn |
| Dec 31, 2021 | 2.53 Mn |
| Sep 30, 2021 | 2.17 Mn |
| Jun 30, 2021 | 2.03 Mn |